Siemens is testing teams of creepy-crawly 3-D-printing robots. Their descendants might make manufacturing lines far more efficient.
AbbVie’s purchase of the cancer fighting startup backed by Peter Thiel’s Founders Fund bodes well for biotech funding.
Google’s founders chose not to pen the company’s annual letter for the first time in 12 years, leaving investors in the dark about Alphabet’s moon shot strategies.
Don’t bet against SpaceX’s ability to land a capsule on Mars. But colonization probably remains further off than it seems.
The technology already exists to give third-party apps and devices access to cable content. The question is whether the cable companies will support it.
A company that powers two million websites is switching on a major upgrade to the protocol that underpins the Web.
Twitter has been developing technology that automatically recognizes what’s happening in live video, a step toward sophisticated recommendations.
OpenAI, a nonprofit created to do artificial intelligence that will benefit everyone, has released a tool to help machines learn through trial and error.
Apple wants to make more money from cloud services—an area it doesn’t traditionally excel in that has many competitors.
A drug company says economic sticks, not just carrots, are needed to fix the reproducibility crisis in science.